Temporal Association Between Incident Tuberculosis and Poor Virological Outcomes in a South African Antiretroviral Treatment Service

被引:0
|
作者
Gupta-Wright, Ankur [1 ]
Wood, Robin [2 ]
Bekker, Linda-Gail [2 ]
Lawn, Stephen D. [1 ,2 ]
机构
[1] Univ London London Sch Hyg & Trop Med, Dept Clin Res, Fac Infect & Trop Dis, London WC1E 7HT, England
[2] Univ Cape Town, Desmond Tutu HIV Ctr, Inst Infect Dis & Mol Med, Fac Hlth Sci, ZA-7925 Cape Town, South Africa
基金
美国国家卫生研究院; 英国惠康基金;
关键词
tuberculosis; HIV; viral load; virological failure; antiretroviral; Africa; HIV-INFECTED PATIENTS; SUB-SAHARAN AFRICA; RISK-FACTORS; VIRAL LOAD; TREATMENT PROGRAMS; DRUG-RESISTANCE; THERAPY; EFAVIRENZ; MORTALITY; FAILURE;
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Introduction: The temporal relationship between incident tuberculosis (TB) and virological outcomes during antiretroviral therapy (ART) is poorly defined. This was studied in a cohort in Cape Town, South Africa. Methods: Data regarding TB diagnoses, ART regimens, and 4-monthly updated viral load (VL) and CD4 count measurements were extracted from a prospectively maintained database. Rates of virological breakthrough (VL > 1000 copies/mL) and failure (VL > 1000 copies/mL on serial measurements) following initial VL suppression were calculated. Poisson models were used to calculate incidence rate ratios (IRRs) and identify risk factors for these virological outcomes. Results: Incident TB was diagnosed in 391 (28.5%) of 1370 patients during a median of 5.2 years follow-up. Five hundred seventy-eight episodes of virological breakthrough and 231 episodes of virological failure occurred, giving rates of 10.0 episodes per 100 person-years and 4.0 episodes per 100 person-years, respectively. In multivariate analyses adjusted for baseline and time-updated risk factors, TB was an independent risk factor for adverse virological outcomes. These associations were strongly time dependent; the 6-month period following diagnosis of incident TB was associated with a substantially increased risk of virological breakthrough (IRR: 2.3, 95% confidence interval: 1.7 to 3.2) and failure (IRR: 2.6, 95% confidence interval: 1.6 to 4.3) compared with time without a TB diagnosis. Person-time preceding TB diagnosis or more than 6 months after a TB diagnosis was not associated with poor virological outcomes. Conclusions: Incident TB during ART was strongly associated with poor virological outcomes during the 6-month period following TB diagnosis. Although underlying mechanisms remain to be defined, patients with incident TB may benefit from virological monitoring and treatment adherence support.
引用
收藏
页码:261 / 270
页数:10
相关论文
共 46 条
  • [41] Comparison of profile and treatment outcomes between elderly and non-elderly tuberculosis patients in Puducherry and Tamil Nadu, South India
    Murali, Sharan
    Krishnamoorthy, Yuvaraj
    Knudsen, Selby
    Roy, Gautam
    Ellner, Jerrold
    Horsburgh, Charles Robert
    Hochberg, Natasha
    Salgame, Padmini
    Babu, Senbagavalli Prakash
    Sarkar, Sonali
    PLOS ONE, 2021, 16 (08):
  • [42] Relationship between Endothelial Function, Antiretroviral Treatment and Cardiovascular Risk Factors in HIV Patients of African Descent in South Africa: A Cross-Sectional Study
    Nkeh-Chungag, Benedicta N.
    Goswami, Nandu
    Engwa, Godwill A.
    Sewani-Rusike, Constance R.
    Mbombela, Vuyolwethu
    Webster, Ingrid
    De Boever, Patrick
    Kessler, Harald H.
    Stelzl, Evelyn
    Strijdom, Hans
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (03) : 1 - 14
  • [43] Predicting Airborne Infection Risk: Association Between Personal Ambient Carbon Dioxide Level Monitoring and Incidence of Tuberculosis Infection in South African Health Workers
    Nathavitharana, Ruvandhi R.
    Mishra, Hridesh
    Sullivan, Amanda
    Hurwitz, Shelley
    Lederer, Philip
    Meintjes, Jack
    Nardell, Edward
    Theron, Grant
    CLINICAL INFECTIOUS DISEASES, 2022, 75 (08) : 1297 - 1306
  • [44] Better Virological Outcomes Among People Living With Human Immunodeficiency Virus (HIV) Initiating Early Antiretroviral Treatment (CD4 Counts ≥500 Cells/μL) in the HIV Prevention Trials Network 071 (PopART) Trial in South Africa
    Fatti, Geoffrey
    Grimwood, Ashraf
    Nachega, Jean B.
    Nelson, Jenna A.
    LaSorda, Kelsea
    van Zyl, Gert
    Grobbelaar, Nelis
    Ayles, Helen
    Hayes, Richard
    Beyers, Nulda
    Fidler, Sarah
    Bock, Peter
    CLINICAL INFECTIOUS DISEASES, 2020, 70 (03) : 395 - 403
  • [45] Temporal trends between association of evidence-based treatment and outcomes in patients with non-ST-elevation myocardial infarction
    Alvarez-Alvarez, Belen
    Abou Jokh Casas, Charigan
    Garcia Acuna, Jose Maria
    Cid Alvarez, Belen
    Agra Bermejo, Rosa Maria
    Cordero Fort, Alberto
    Rodriguez Manero, Moises
    Gude Sampedro, Francisco
    Gonzalez-Juanatey, Jose R.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 260 : 1 - 6
  • [46] Treatment outcomes of children with Hodgkin lymphoma between 2000 and 2010: First report by the South African Children's Cancer Study Group
    Geel, Jennifer A.
    Chirwa, Tobias C.
    Rowe, Biance
    Eyal, Katherine C.
    Omar, Fareed
    Stones, David K.
    Goga, Yasmin
    Stefan, D. Cristina
    van Zyl, Anel
    Van Emmenes, Barry
    Wedi, Oloko
    Vaithilingum, Manickavallie
    Hendricks, Marc G.
    PEDIATRIC BLOOD & CANCER, 2017, 64 (10)